ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Scottish biotech PhaSER Biomedical wins a $2.7M Gates Foundation grant to develop AI tools for infectious disease drugs. The funding supports its 8HUM mouse model and HERALD AI tool, following a previous $2.3M award in 2024. The company also hired AI experts and appointed Exscientia co-founder Richard Bickerton to its board.
Tap to vote and see what everyone thinks.
Summary by ByteBrief
DropGenie Raises $5M for AI Drug Tools

Atlas Bio Raises $12.5M for AI Drug Trials

CrowdStrike agrees to buy Fiddler AI, which helps monitor AI agents, for ~$400M, and Dreadnode, an automated security AI testing tool, for ~$95M, mostly in cash (James Rundle/Wall Street Journal)